Floseal
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Intraoperative Bleeding
Conditions
Intraoperative Bleeding, Post-operative Bleeding
Trial Timeline
Jan 1, 2012 → Jan 1, 2017
NCT ID
NCT01891461About Floseal
Floseal is a approved stage product being developed by Baxter for Intraoperative Bleeding. The current trial status is completed. This product is registered under clinical trial identifier NCT01891461. Target conditions include Intraoperative Bleeding, Post-operative Bleeding.
What happened to similar drugs?
0 of 2 similar drugs in Intraoperative Bleeding were approved
Approved (0) Terminated (0) Active (2)
Hype Score Breakdown
Clinical
20
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01974193 | Phase 3 | UNKNOWN |
| NCT01891461 | Approved | Completed |
Competing Products
3 competing products in Intraoperative Bleeding
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| pudexacianinium chloride | Astellas Pharma | Phase 3 | 40 |
| pudexacianinium chloride | Astellas Pharma | Phase 3 | 40 |
| Rocuronium | Merck | Pre-clinical | 26 |